← Back to Clinical Trials
Recruiting NCT06311162

Early Life Intervention in Pediatrics Supported by E-health - SMOKE

Trial Parameters

Condition Smoking Reduction
Sponsor Insel Gruppe AG, University Hospital Bern
Study Type INTERVENTIONAL
Phase N/A
Enrollment 160
Sex ALL
Min Age N/A
Max Age 5 Years
Start Date 2024-05-07
Completion 2027-08-31
Interventions
Life-Style appSham Comparator

Brief Summary

Unrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCDs in children, i.e. asthma. Early preventive measures to improve lifestyle behavior in parents are therefore of utmost importance. The aim of ELIPSE-II is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering levels of urinary cotinine as a measure of second-hand smoke exposure in their children .

Eligibility Criteria

Inclusion Criteria: * Age: younger than 6 years * Exposed to second-hand smoke at home (at least one parent smoking) * German speaking parent * All sex and ethnic backgrounds * Signed informed consent form from parent * Children live/grow-up in the same household as the parental participant * Referred by a health care professional (e.g. physician, midwife, nurse, other professions) Exclusion Criteria: * Participation in another study/trial targeting similar outcomes * Participation in an active smoking cessation programme

Related Trials